Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Equillium to Present at Oppenheimer...
Business investor conference

Equillium to Present at Oppenheimer Conference

Analysis based on 7 articles · First reported Apr 20, 2026 · Last updated Apr 20, 2026

Sentiment
10
Attention
2
Articles
7
Market Impact
Direct
Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard
Market Impact

The announcement of Equillium's presentation at Oppenheimer's 2026 Innovation on the Island Event provides an opportunity for investors to learn more about Equillium's therapeutic pipeline, potentially influencing its stock performance. This event could generate increased investor interest in Equillium and the biotechnology sector.

Biotechnology Pharmaceuticals
Event Summary

Equillium, Inc., a biotechnology company focused on autoimmune and inflammatory disorders, announced that its management team will present at Oppenheimer's 2026 Innovation on the Island Event on April 28, 2026. This presentation offers Equillium an opportunity to engage with investors and discuss its lead therapeutic candidate, EQ504, an aryl hydrocarbon receptor (AhR) modulator. EQ504 is being developed for conditions such as ulcerative colitis and inflammatory lung diseases. The event allows Equillium to highlight its innovative therapies and potentially attract new investment.

Key Actions
95 Equillium will present at Oppenheimer's 2026 Innovation on the Island Event Oppenheimer Holdings
90 Equillium announced presentation at investor conference
Entities Involved
stock
Equillium
Equillium will present at Oppenheimer's 2026 Innovation on the Island Event, providing an opportunity to engage with investors and discuss its therapeutic candidates like EQ504.
Importance 100 Sentiment 10
priv
Oppenheimer Holdings
Oppenheimer Holdings is hosting the 2026 Innovation on the Island Event, where Equillium will be presenting. This event provides a platform for companies to connect with investors.
Importance 50 Sentiment 0
exch
Nasdaq
Equillium is listed on Nasdaq under the ticker symbol EQ, indicating its status as a publicly traded company.
Importance 10 Sentiment 0
priv
LifeSci Advisors
LifeSci Advisors is listed as the investor contact for Equillium, facilitating communication between Equillium and investors.
Importance 10 Sentiment 0
per
PJ Kelleher
PJ Kelleher is the investor contact at LifeSci Advisors for Equillium.
Importance 5 Sentiment 0
Relationships
LifeSci Advisors related ↔ Equillium
PJ Kelleher related ↔ LifeSci Advisors
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.